GMS SFE 2026/27: Why the Headlines Look Better Than the Reality for Many Practices

The 2026/27 GMS Statement of Financial Entitlements does bring some movement in the right places, especially through Global Sum. But for many practices, this is unlikely to feel like a genuinely better year financially. Once flat funding lines, weaker dispensing income, rising pay costs and growing workload are taken into account, this looks less like a breakthrough and more like another attempt to stand still in a rising-cost environment.

There is some welcome movement in the contract. The problem is that much of the pressure sitting around it has moved as well — and in several areas, it has moved faster.

Quick links

The Practice Connect view

Our view is that the 2026/27 settlement is being talked up more positively than many practices are likely to experience it. That does not mean there are no positives in it. There are. A stronger Global Sum matters, especially after years in which core funding has felt too thin and too heavily reliant on variable income elsewhere.

But that is only part of the story. Once you look beyond the headline numbers, this starts to feel more like a stabilisation package than a genuinely growth-focused settlement. Some areas are flat. Some appear to have been folded into Global Sum rather than added on top. Dispensing looks worse. Capacity and Access has disappeared from one place without yet clearly reappearing in another. And all of that is landing at the same time as continuing pay pressures and rising workload.

In plain English, the contract is not really solving the core problem many practices feel every day. The core problem is not simply whether funding moves at all. It is whether funding moves far enough, and cleanly enough, to keep pace with costs and the amount of work flowing into general practice.

That is why we think the more honest reading is this: there is some welcome movement in the baseline, but for many practices the year ahead may still feel financially tight, operationally stretched and strategically uncertain.

In one line

This looks more like a contract designed to help practices keep their balance than one designed to move them forward.

Global Sum: the main source of uplift, but not a clean win for everyone

The most obvious improvement in the 2026/27 SFE comes through Global Sum, and that should be recognised. For practices that have spent the last few years watching costs rise faster than their baseline income, a stronger core funding line is clearly better than standing still.

But even here, the detail matters. The benefit will not land evenly. Practices with stronger Carr-Hill weighting are likely to feel the gain more clearly than those with weaker weighting. And some of the uplift may feel less generous in practice once you strip out funding that appears to have been rolled into core funding rather than added as genuinely fresh money.

That means the right reading is not “Global Sum is up, so practices are better off.” The more accurate reading is “Global Sum is up, and for some practices that will make a meaningful difference — but not every practice will feel it in the same way, and not all of the uplift will feel like new headroom.”

So yes, this is the clearest positive in the contract. It is just not a universal one, and it is not enough on its own to make the broader pressures disappear.

Summary

Global Sum is where the real movement is. The problem is that many practices need more than movement; they need margin.

QOF: more points on paper, but probably not the windfall some headlines imply

QOF will attract attention because the total points available rise, and the framework changes in visible ways. That makes it easy to present QOF as a meaningful gain within the new contract year.

The more cautious reading is that this should not be overstated. Yes, there are additional points in the system, and yes, there are new areas such as obesity and revised cardiovascular arrangements. But for many practices, the real-world gain may feel modest once the operational workload needed to secure those points is taken into account.

In other words, this is not a case of free money arriving politely through the front door. It is a more complicated offer than that. Practices may be able to earn more, but they may also need to do more, document more and organise more to get there. And if the underlying value does not move meaningfully in real terms, then the practical effect is far less impressive than the headlines can make it sound.

Our view is that QOF still matters, of course it does, but it should be seen as a tighter, more conditional opportunity, not as the main financial story of the contract. The main financial story is still Global Sum. QOF sits behind that.

What improved

There are more points in the framework and some new areas of focus.

What that does not mean

It does not automatically mean a meaningful real-terms uplift for the average practice.

What the risk is

Practices could end up working harder for only limited additional return.

Summary

QOF still matters, but it should not distract from the fact that the real contract movement is much more concentrated in core funding than in performance-related uplift.

Where funding still looks flat

One of the reasons this contract feels less generous than the headlines suggest is that too much of the wider funding picture still looks flat. If you are only looking at the strongest headline, the settlement can sound more positive than it is. If you look across the full spread of income lines, the picture becomes much more restrained.

That matters because practices do not run on one number. They run on the combined effect of core income, QOF, enhanced services, vaccination income, dispensing where relevant, network-related funding, local schemes and the general predictability of what sits around all of that.

Where several of those lines are flat, or where the movement is unclear, the pressure falls back onto the one area that has improved more visibly. That is part of why the Global Sum uplift matters so much — because it is carrying more of the weight than it ideally should.

What practices are likely to notice

  • Immunisations and vaccinations funding does not look like a major growth story.
  • PCN participation does not look like a source of fresh financial relief.
  • Some funding appears to have been moved into core income rather than added on top.
  • The overall package feels uneven, with one stronger line carrying several flatter ones.

Dispensing: one of the clearest areas where some practices may simply be worse off

Dispensing is one of the easiest areas to skip past when people are talking about headline contract changes, but for dispensing practices it matters a great deal. And the problem here is fairly straightforward: the direction of travel looks unhelpful.

In simple terms, this is not a section of the contract that feels like it is trying to ease financial pressure. If your practice depends meaningfully on dispensing income, then the new feescales need to be reflected in your forecast early, because leaving old assumptions in place is a good way to flatter the budget and disappoint yourself later.

The broader point is that this reinforces the unevenness of the overall settlement. While one part of the contract can be presented as stronger, another part is moving in the opposite direction. So the average practice experience depends very heavily on which income lines matter most to it.

Summary

For dispensing practices, this does not feel like a footnote. It feels like one more reason the contract may be less generous in practice than it first appears.

Capacity and Access: the awkward gap in the middle of the picture

One of the biggest unresolved issues is Capacity and Access. The difficulty is not just whether the money exists in some form somewhere in the system. The difficulty is that, from a practical planning point of view, practices and PCNs need clarity on what is replacing what, and when.

That uncertainty matters now, not later. PCNs cannot make sensible staffing and delivery decisions on the basis of good wishes and background optimism. If a funding stream disappears from one place without clearly reappearing at practice level, that creates a genuine hole in planning and potentially a real financial exposure if costs remain but the underlying support mechanism has changed.

For many practices, this may turn out to be one of the most important parts of the story, even though it is not the cleanest headline. It is exactly the kind of issue that can leave practices looking reasonable on paper while feeling increasingly uncomfortable in live operational terms.

Why this matters

If practices end up picking up costs that were previously absorbed through PCN-level funding arrangements, then the contract could feel materially worse than the headline numbers suggest.

The cost side of the equation: this is where the optimism starts to wobble

The biggest weakness in any overly positive reading of the 2026/27 contract is that it tends to talk about income in isolation. Practices do not experience income in isolation. They experience it against the cost of employing staff, maintaining services, covering inflationary pressure and absorbing whatever new workload lands next.

And that is where the settlement starts to look much less comfortable. Pay pressures are still there. Wage pressures are still there. Wider inflationary pressures are still there. Other operating costs are not exactly queueing up to become more affordable either.

That means the right test is not “has contract funding gone up?” It is “has contract funding gone up enough?” For many practices, the honest answer may be no, or at least not by much. And that is before you even get to the question of whether demand and workload are rising faster than either funding or staffing capacity.

This is why the contract may feel, for a lot of practices, like inflationary catch-up rather than genuine financial progress. There is movement, yes. Headroom is another matter.

Summary

If costs rise at the pace many practices expect, then even a better-looking contract can still feel financially tight.

Looking past the headline uplift

One of the risks with any new contract settlement is that the headline figures can make the overall position look stronger than it will feel in day-to-day practice. This year is a good example of that.

On paper, the settlement has enough visible movement for people to present it as a step forward. But when you strip it back, the overall picture looks much more mixed. The main uplift sits in core funding. Several other lines do not appear to offer much fresh relief. Some funding seems to have been moved around. Meanwhile, costs, demand and uncertainty continue to move in the wrong direction.

That is why the contract may land very differently across the sector. A well-weighted practice with tighter cost control may get through the year reasonably well. A practice with poorer weighting, higher employed staff costs, dispensing exposure or greater dependence on unresolved PCN-related funding may look at exactly the same contract and conclude that it is doing little more than helping them wash their face.

And that may be the most honest summary of all. For the average practice, this does not look like a transformation. It looks like an attempt to stop the financial position deteriorating too quickly.

Practice Connect take

The 2026/27 settlement feels more like a holding measure than a reset. There is enough in it for some practices to fare reasonably well, but not enough for many to feel genuinely comfortable.

The real story: workload is still rising faster than resource

Even if you park the contract wording to one side for a moment, the bigger issue remains workload. Demand is up. General practice is carrying more. Advice and Guidance changes may shift even more work into practices without any clear sense of matching resource. And none of that pressure disappears just because a headline funding figure has improved.

That is why the real feeling many practices may have this year is not “the contract is better” but “the work is still getting harder.” And if the work gets harder faster than the money improves, then the lived experience of the contract remains one of pressure, not relief.

That, more than any one funding line, is probably the real story of 2026/27.

What remains uncertain

There are also some significant uncertainties hanging over the year ahead, and they matter because practices are being asked to plan in the middle of them. Carr-Hill remains a live issue. Wider neighbourhood and PCN reform remains a live issue. The future of some local enhanced services remains a live issue. None of those are minor background details.

For many practices, the difficulty is not just the current contract value. It is the fact that the shape of the wider landscape still feels unsettled. That makes it harder to plan workforce, harder to plan service lines and harder to feel confident about where exactly the financial risk will sit over the next 12 months.

In short, this is not just a year of tight margins. It is also a year of strategic uncertainty.

What this means for partners

For partners, the message is fairly stark. Do not read the contract headlines and assume the practice is safer than it was. Read the whole funding picture, test the budget properly and be realistic about where pressure is sitting.

This year needs more than casual reassurance. Partners should want to know exactly how much of the uplift is real, how much is uneven, where the practice is exposed, and whether any PCN-level changes could leave costs landing in a different place from before.

In practical terms, the key partner task is not celebration. It is vigilance.

What practice managers should do now

  1. Rebuild the 2026/27 financial model from the ground up.
    Do not rely on last year’s assumptions with a few uplifts dropped in. Rework the baseline properly.
  2. Stress-test the model against cost inflation.
    A contract that looks acceptable before pay pressure can look a lot less comfortable after it.
  3. Review every line that looks flat or uncertain.
    Flat income lines and unresolved funding changes matter just as much as the uplift lines.
  4. Refresh operational assumptions, not just financial ones.
    If workload is rising, then staffing, coding, recall and admin processes need looking at too.
  5. Put ownership against the unresolved issues.
    Especially Capacity and Access, PCN impacts, and any local scheme exposure.

Biggest winners / biggest risks

Who may do relatively better

  • Practices with stronger Carr-Hill weighting.
    They are more likely to feel the Global Sum uplift clearly.
  • Practices with tighter employed staff cost bases.
    Lower cost pressure creates more chance of retaining benefit from the uplift.
  • Practices less exposed to weaker funding lines.
    If you are less dependent on the flatter or more uncertain parts of the package, the year may feel more manageable.
  • Practices with strong financial grip.
    Good modelling and early adjustment will matter more than ever.

Who may feel the pressure most

  • Practices with weaker weighting.
    The main uplift may simply not go as far.
  • Practices with higher staff cost exposure.
    Pay pressure can eat through the gain quickly.
  • Dispensing practices.
    They may see the contract move against them in one of their key income lines.
  • Practices exposed to unresolved PCN funding changes.
    Especially where costs may remain but support mechanisms are unclear.

Summary

The average practice may feel like this contract helps it cope. The better-positioned practice may feel like it can gain. The more exposed practice may feel like it is still going backwards, just slightly more slowly.

5 questions to ask your finance or QOF lead now

  1. How much of the uplift is genuinely new money to the practice, and how much is movement within the system?
  2. What does the 2026/27 budget look like after staffing costs and inflation, not before?
  3. How exposed are we to weaker dispensing income or unresolved PCN funding changes?
  4. Which parts of the contract look better in headlines than they will in our own numbers?
  5. If demand keeps rising, where does the extra work land — and who is paying for it?

Final word

There are some positives in the 2026/27 GMS SFE. It would be wrong to pretend otherwise. But it would also be wrong to present this as a contract that meaningfully changes the financial mood of general practice.

For many practices, the reality is likely to be tougher than the headline. Global Sum is doing most of the heavy lifting. Other areas look flat or uncertain. Dispensing looks worse. Costs are still rising. Demand is still rising. Workload is still rising. And some of the biggest questions around the wider operating model remain unresolved.

So the fairest verdict is probably this: the contract may help some practices stand a bit steadier, but for many it will still feel like another year of trying to absorb more pressure than the settlement truly relieves.